The Global Constipation Market Report: 2016 Edition research of 52 pages with 37 Charts and 6 Tables, 4 company profiles to the pharmaceuticals industry segment of its online data and intelligence library, now available at http://www.marketreportsonline.com/463724.html.
Constipation is a common medical condition common among elderly and women, and is interpreted differently by patients and physicians. Constipation can be chronic, sometimes severe, and has a significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three main types of constipation including Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome (IBS-C) and Opioid Induced Constipation (OIC).
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.
Purchase a copy of this Constipation Market research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=463724.
The report, “Global Constipation Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S. Japan China and Europe are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.
Table of Contents Provided in Constipation Market 2016 Edition Report:
1. Market Overview
1.2.1 Chronic Idiopathic Constipation (CIC)
1.2.2 Irritable Bowel Syndrome with Constipation (IBS-C)
1.2.3 Opioid-Induced Constipation (OIC)
1.3 Etiology/ Causes
1.3.1 Extrinsic Causes
1.3.2 Intrinsic Causes
1.4 Treatment Options
1.4.1 Pharmacological Treatment
1.4.2 Non Pharmacological Treatments
2. Constipation Market Analysis
2.1 The U.S.
2.1.1 The U.S. Constipation Market by Value
2.1.2 The U.S. Constipation Market Value by Type
2.1.3 The U.S. Constipation Market by Volume
2.1.4 The U.S. Constipation Market Volume by Type
2.1.5 The U.S. Constipation Market by Drug Type
2.1.6 The U.S. Constipation Market by Drug
2.2.1 Japan’s Constipation Market by Volume
2.2.2 Japan’s Constipation Drug Market
3. Chronic Constipation Market Analysis
3.1 The U.S. Chronic Constipation Market by Volume
3.2 European Chronic Constipation Market by Volume
4. Irritable Bowel Syndrome Market Analysis
4.1 The U.S. IBS-C Market by Volume
4.2 European IBS-C Market by Volume
5. Opioid Induced Constipation Market Analysis
5.1 The U.S. Opioid Induced Constipation Market by Volume
5.1.1 The U.S. Opioid Induced Constipation Drugs Market
5.2 European Opioid Induced Constipation Market by Volume
5.2.1 European Opioid Induced Constipation Drug Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Consumption of Prescription Opioid Drugs in the U.S.
6.1.2 Growing Ageing Population
6.1.3 Vast Opportunity with Significant Potential in the U.S.
6.1.4 Global Spending on Medicines
6.1.5 Growing Female Population
6.1.6 Rising Healthcare Expenditure
6.2 Key Trends
6.2.1 Drugs under Development for Constipation
6.2.2 Market Opportunity for Pediatric Constipation
6.3.1 Rising Tide of Over-The-Counter Drugs for Constipation
6.3.2 Low Awareness of Prescription Medications for OIC
7. Competitive Landscape
8. Company Profiles
Other Related Reports on pharmaceuticals Market:
Global In Vitro Fertilization (IVF) Market Report: 2016 Edition (http://www.marketreportsonline.com/463825.html) In Vitro Fertilization (IVF) is a process of fertilizing the egg outside the body. It is helpful for those couples who are suffering from infertility and hence are not able to conceive a child but want to have a family. There has been an increase in infertility cases globally for which many factors are responsible like increasing late marriages because of the career perspective.
Global Peripheral Artery Disease (PAD) Market: Trends & Opportunities (2015-2020) (http://www.marketreportsonline.com/444808.html) This report includes the analysis of global peripheral artery disease device market by value and by product types. This segment of report also includes the sizing and growth of global PAD angioplasty market and global PAD stent market, with focus on drug coated balloons (DCB) market and drug eluting stents (DES) market. Furthermore, this report also provides the analysis of United States’ peripheral artery disease market.
Global Peripheral Artery Disease Market Report: 2016 Edition (http://www.marketreportsonline.com/466737.html) Peripheral Artery Disease (PAD) is a medical condition in which plaque builds up on the artery walls, blocking the flow of oxygen-rich blood to the legs, stomach, and arms. Major factors causing PAD are smoking, diabetes, high blood pressure, abnormal cholesterol levels, advancing age and a personal history of vascular disease.
Global Hemophilia Market Report: 2016 Edition (http://www.marketreportsonline.com/463723.html ) Hemophilia refers to a set of hereditary genetic disorders that impairs the body’s ability to control blood clotting, which controls bleeding when a blood vessel is broken. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. In the absence of a treatment, uncontrolled internal bleeding can occur, causing stiffness, pain, severe joint damage and even death.